Influenza Vaccines
Research from Centers for Disease Control and Prevention Has Provided New Information about Influenza Vaccines
Published in Vaccine Weekly, March 7th, 2012
2012 MAR 7 -- A report, "Neuraminidase inhibitor resistance in influenza viruses and laboratory testing methods," is newly published data in Antiviral Therapy. "Infection with influenza viruses, including seasonal, avian and pandemic viruses, remains a worldwide public health problem. Although influenza virus infection is both vaccine preventable and drug treatable, high rates of mutation and reassortment of viruses can result in reduced effectiveness of vaccines or drugs," scientists in Atlanta, Georgia report.
"Currently, two classes of drugs, adamantanes (M2 blockers) and neuraminidase (NA) inhibitors (NAIs), are available for treatment and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2012-03-07)
More Articles from Vaccine Weekly
- Vaccination
New Data from Bar-Ilan University Illuminate Research in Vaccination - Pediatric Vaccines
New Findings from Children's Hospital Describe Advances in Pediatric Vaccines - Mucosal Immunization
Reports from Center for Infection Add New Data to Research in Mucosal Immunization - Pediatric Vaccines
Research Findings from Osaka Rosai Hospital Update Understanding of Pediatric Vaccines - Phosphorus-Oxygen Lyases
Research Reports from Masaryk University Provide New Insights into Phosphorus-Oxygen Lyases - Pediatrics
Study Data from D. Antai et al Provide New Insights into Pediatrics - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
